The mutant variant has the opposite effect to wild type (WT) p53 by the “gain of function” (GOF) phenomenon, thus contributing to the increase of the resistance to treatment of the malignant cell but also promoting the tumor progression. This evidence concerns the gene TP53 and neoplasm.